Medartis Holding AG
SIX:MED

Watchlist Manager
Medartis Holding AG Logo
Medartis Holding AG
SIX:MED
Watchlist
Price: 91.1 CHF 2.94% Market Closed
Market Cap: 1.2B CHF
Section:
 

Relative Value

The Relative Value of one MED stock under the Base Case scenario is hidden CHF. Compared to the current market price of 91.1 CHF, Medartis Holding AG is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MED Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

4.8
P/S
P/S
Price to Sales
4.8
vs History
50
vs Industry
30
Median 3Y
4.5
Median 5Y
4.7
Industry
2.3
Forward
4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
1
Median 3Y
-136.3
Median 5Y
-127.8
Industry
22.5
Forward
88.4
More Details
36
P/OCF
P/OCF
Price to OCF
36
vs History
52
vs Industry
12
Median 3Y
28.6
Median 5Y
43.4
Industry
14.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
36
Median 3Y
-33.4
Median 5Y
-33.4
Industry
21.5
More Details
4.3
P/B
P/B
Price to Book Value
4.3
vs History
25
vs Industry
25
Median 3Y
3.7
Median 5Y
3.8
Industry
2.2
More Details
4.8
EV/S
EV/S
Enterprise Value to Sales
4.8
vs History
57
vs Industry
28
Median 3Y
4.6
Median 5Y
4.7
Industry
2.6
Forward
4
More Details
6
EV/GP
EV/GP
Enterprise Value to Gross Profit
6
vs History
50
vs Industry
43
Median 3Y
5.7
Median 5Y
6
Industry
5.2
More Details
31.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
31.3
vs History
65
vs Industry
10
Median 3Y
31.8
Median 5Y
35.9
Industry
11.9
Forward
25
More Details
88
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
88
vs History
71
vs Industry
3
Median 3Y
90.8
Median 5Y
114.9
Industry
16.9
Forward
52.8
More Details
35.9
EV/OCF
EV/OCF
Enterprise Value to OCF
35.9
vs History
52
vs Industry
13
Median 3Y
27.8
Median 5Y
38.7
Industry
14.7
More Details
58.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
58.6
vs History
33
vs Industry
10
Median 3Y
45.8
Median 5Y
45.8
Industry
18.7
More Details
3.4
EV/IC
EV/IC
Enterprise Value to IC
3.4
vs History
36
vs Industry
27
Median 3Y
3
Median 5Y
3.1
Industry
1.9
More Details

Multiples Across Competitors

MED Competitors Multiples
Medartis Holding AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Medartis Holding AG
SIX:MED
1.1B CHF 4.8 -2 323 31.3 88
JP
Hoya Corp
TSE:7741
8.2T JPY 9.4 39.6 25 29.8
CH
Alcon AG
SIX:ALC
32.3B CHF 4 37.5 16.4 31.7
DK
Coloplast A/S
CSE:COLO B
131B DKK 4.7 36 16.5 19.6
US
Align Technology Inc
NASDAQ:ALGN
11.3B USD 2.8 29.9 13.6 17.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
47B CNY 10.3 28.5 26.2 26.2
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP 2.7 28.9 224.1 364.2
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD 1.2 -19.5 19.5 91.9
CH
Ypsomed Holding AG
SIX:YPSN
4.4B CHF 5.9 50.1 24.4 41.8
JP
Asahi Intecc Co Ltd
TSE:7747
825.5B JPY 6.9 64.8 19.4 25.9
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.9B USD 3.3 41.8 19 31.6
P/E Multiple
Earnings Growth PEG
CH
Medartis Holding AG
SIX:MED
Average P/E: 39.7
Negative Multiple: -2 323
110%
N/A
JP
Hoya Corp
TSE:7741
39.6
12%
3.3
CH
Alcon AG
SIX:ALC
37.5
25%
1.5
DK
Coloplast A/S
CSE:COLO B
36
23%
1.6
US
Align Technology Inc
NASDAQ:ALGN
29.9
27%
1.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
28.5
10%
2.9
UK
ConvaTec Group PLC
LSE:CTEC
28.9
32%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.5 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
50.1
34%
1.5
JP
A
Asahi Intecc Co Ltd
TSE:7747
64.8
34%
1.9
US
Merit Medical Systems Inc
NASDAQ:MMSI
41.8
30%
1.4

See Also

Summary
MED intrinsic value, competitors valuation, and company profile.
DCF Valuation
MED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MED stock valuation using valuation multiples.
Wall Street Estimates
MED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 301,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.